FDA accepts Bayer's application to expand Kerendia to CKD without diabetes
Bayer announced that the U.S. Food and Drug Administration has accepted a supplemental New Drug Application (sNDA) for Kerendia (finerenone) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

